ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
Evaluation of innovative promising fungicide from nitropyrazolone class: effects on phytopathogens and non-target organisms.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The search for new fungicides is increasingly critical due to significant losses in crop quality and quantity caused by fungal diseases, as well as the development of resistance among pathogens to existing plant protection products. This study focuses on the evaluation of previously hardly known nitropyrazolone, 4,5-dimethyl-4-nitro-2-phenyl-2,4-dihydro-3 H-pyrazol-3-one, for its fungicidal properties. The antifungal activity of this compound was assessed against common phytopathogens, including Sclerotinia sclerotiorum, Alternaria alternata, Verticillium dahliae, and Fusarium graminearum, utilizing both in vitro and in vivo methods. Results indicated that the test compound effectively suppressed the growth of phytopathogens in laboratory tests, achieving maximum inhibition rates of 80% against S. sclerotiorum, minimum inhibition rates of 58% against V. dahliae, In vivo assessments conducted on cherry tomatoes demonstrated a 1.3-fold reduction in disease incidence caused by F. graminearum when treated with the test compound at a concentration of 0.01%. To evaluate the safety profile of the test compound concerning non-target organisms, phytotoxicity tests were performed on spring oats (Avena sativa) and radishes (Raphanus sativus), revealing no phytotoxic effects. Additionally, minimum inhibitory concentrations (MICs) were determined for common pathogens (Pseudomonas aeruginosa and Escherichia coli) and two strains typical of the soil microbial community, which are frequently used as biocontrol agents (Pseudomonas fluorescens and Bacillus subtilis). Thus, primary screening results suggest that the test compound has potential as an effective fungicide that does not exhibit toxicity toward plants or beneficial bacteria.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.